ICLR

ICON plc
D

ICLR

163.720
USD
-4.94
(-2.93%)
Market Closed
Volume
33,667
EPS
14
Div Yield
-
P/E
17
Market Cap
13,231,974,336
Related Instruments
NEOUSD
NEOUSD
0.02634
(0.56%)
4.69013 USD
B
BIO
-10.795
(-4.40%)
234.775 USD
C
CRL
-8.420
(-5.64%)
140.940 USD
DGX
DGX
2.710
(1.61%)
170.620 USD
ILMN
ILMN
-5.450
(-6.66%)
76.370 USD
LH
LH
-3.020
(-1.28%)
233.360 USD
MTD
MTD
-79.47
(-6.76%)
1,095.28 USD
N
NEO
-0.67000
(-7.12%)
8.74000 USD
Q
QDEL
-2.130
(-6.16%)
32.470 USD
TMO
TMO
-18.94
(-3.87%)
470.10 USD
WST
WST
-1.640
(-0.74%)
219.970 USD
More
News

Title: ICON plc

Sector: Healthcare
Industry: Diagnostics & Research
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.